Related Experiment Video
Updated: Feb 14, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
ALS-related human cortical and motor neurons survival is differentially affected by Sema3A
Anastasya Birger1,2, Miri Ottolenghi2, Liat Perez1
1Department of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada (IMRIC), Faculty of Medicine, The Hebrew University, P.O. Box 12272, 91120, Jerusalem, Israel.
Abstract:
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cell death of upper and lower motor neurons (MNs). The cause of MN cell loss is not completely understood but involves both cell autonomous and non-cell autonomous mechanisms. Numerous molecules have been implicated to be involved in the death of MNs. One such candidate is semaphorin 3A (Sema3A). In ALS patients, Sema3A was shown to be significantly upregulated in the motor cortex and downregulated in the spinal cord. In the mouse, Sema3A was shown to be an axon repellent molecule for MNs. Sema3A could also induce death of different neuronal types that are also repelled by it, including sensory, sympathetic, retinal, and cortical neurons. In contrast, astrocyte-specific knockout of Sema3A results in motor neuron cell death, consistent with the idea that Sema3A is a survival factor for mouse motor neurons. Here, we tested the response of human cortical neurons and spinal cord MNs to Sema3A. We found that Sema3A enhances the survival of spinal cord MNs. In contrast, Sema3A reduces the survival of cortical neurons. Thus, both upregulation of Sema3A in the cortex, or downregulation in the spinal cord of ALS patients is likely to directly contribute to MNs cell loss in ALS patients.
Insights
Semaphorin 3A (Sema3A) differentially affects motor neuron survival. Upregulation in the cortex and downregulation in the spinal cord may contribute to motor neuron loss in amyotrophic lateral sclerosis (ALS).
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Amyotrophic lateral sclerosis (ALS) involves motor neuron (MN) cell death, with mechanisms not fully understood.
- Semaphorin 3A (Sema3A) is implicated in neurodegeneration, showing altered levels in ALS patients.
- Sema3A's role in MN survival is complex, with conflicting evidence from mouse models.
Purpose of the Study:
- To investigate the direct effects of Semaphorin 3A (Sema3A) on human cortical neurons and spinal cord motor neurons (MNs).
- To determine if Sema3A's differential expression in ALS contributes to MN cell loss.
Main Methods:
- Culturing human cortical neurons and spinal cord motor neurons.
- Exposing neurons to Semaphorin 3A (Sema3A) to assess survival rates.
Main Results:
- Semaphorin 3A (Sema3A) enhanced the survival of human spinal cord motor neurons.
- Semaphorin 3A (Sema3A) decreased the survival of human cortical neurons.
- Observed differential effects align with Sema3A expression changes in ALS patients.
Conclusions:
- Altered Semaphorin 3A (Sema3A) levels in the motor cortex and spinal cord may directly contribute to motor neuron degeneration in ALS.
- Sema3A acts as a survival factor for spinal cord motor neurons but is detrimental to cortical neurons.
- Understanding Sema3A's dual role is crucial for developing targeted ALS therapies.
Related Concept Videos
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Assumptions of Survival Analysis

